Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

INSANE: 2 | Rare Historical Photos

'It was all through my body': tradie's blunt message for outdoor workers

A big work and safety issue that needs more understanding.

Newcastle Herald

First video of immune cells eating live skin cancer in real time

For the past 15 years or so, a class of drugs called immune checkpoint inhibitors have been used to treat melanoma – the most dangerous kind of skin cancer.

The Conversation

Deadliest Skin Cancer Cases Hit Record High in the UK as Experts Blame Sun Exposure and Sunbed Use

UK melanoma cases hit a record high with 20,000+ yearly diagnoses as experts warn excessive UV exposure and sunbed use raise risks.

International Business Times UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Melanoma skin cancer cases in UK hit record level, analysis finds

Cancer Research UK figures show number diagnosed with most serious form of skin cancer has risen above 20,000 for first time

The Guardian - UK

Melanoma skin cancer cases hit record high in the UK as heatwave warning issued

Cancer Research UK urged people to enjoy the sun safely by covering up and using sunscreen

The Independent UK

Sun safety warning issued for bank holiday as skin cancer cases hit record high

Cancer Research UK data for the year 2022 shows there were 20,980 new cases of melanoma, the highest number it has ever seen.

Evening Standard

Aura Biosciences Highlights Bel-Sar Eye Cancer Strategy, Mid-Year Bladder Data

Aura Biosciences (NASDAQ:AURA) executives outlined the company’s strategy for its lead candidate bel-sar during a session at the H.C. Wainwright Connect Conference, emphasizing ocular oncology as the company’s initial development focus while also discussing ongoing work in non-muscle invasive bladde

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

Regeneron Sinks 10% on Failed Phase 3 Melanoma Trial. What Comes Next for REGN Stock.

Regeneron stock sinks as fianlimab Phase 3 trial fails to meet primary endpoint. But RBC continues to see significant upside in REGN shares from here.

Barchart

IDEAYA Biosciences Says Melanoma Drug on Track for NDA After Strong Trial Data

IDEAYA Biosciences (NASDAQ:IDYA) said its lead oncology program remains on track for a regulatory submission after reporting positive top-line data in first-line metastatic melanoma, while also highlighting several pipeline programs during a presentation at the Bank of America Global Healthcare Conf

MarketBeat

RFK Jr withdraws proposal banning teens from tanning beds as skin experts warn of cancer risks

Using tanning beds can triple a person’s risk of melanoma, according to experts

The Independent UK

Skin cancer warning as one in nine Britons admit to deliberately burning themselves to tan

Research shows that having five or more sunburns doubles your risk of getting melanoma skin cancer

The Independent UK

Teddi Mellencamp claims doctor denied her GLP-1s after weight gain from cancer treatment

The reality star was diagnosed with melanoma in 2022, with her condition advancing to stage four last year

The Independent UK

Your gut bacteria could determine your skin cancer risk - but there’s a catch

Researchers found that differences in the amount of key bacterial groups in the gut predicted cancer recurrence with up to 94% accuracy

The Independent UK

AI can identify people at risk of melanoma years before diagnosis, study finds

Swedish researchers have used AI to spot high-risk melanoma patients before they develop the disease, using health data from existing medical records.

Euronews

Get all your
news in one place.

100's of premium titles.
One news app.

Sports Illustrated

ESPN Legend Dick Vitale Announces Melanoma Diagnosis: ‘I Plan on Winning This Battle’

Vitale has endured bouts with four different forms of cancer.

The Independent UK

I thought my facial mole was harmless — until my doctor warned it could be skin cancer

Skin cancer is the most common type of cancer, with more than two million cases expected this year. The Independent’s Julia Musto thought she might be one of them

The Conversation

Australian children now have half as many moles as kids in 1992. That’s good news for melanoma risk

About one in two Australians will be diagnosed with skin cancer by age 70. The most dangerous kind is melanoma, which develops in skin cells called melanocytes that have been overexposed to the sun.

BANG Premier

Teddi Mellencamp's daughter given her strength amid cancer fight

Teddi Mellencamp has credited her “miracle baby” Dove with giving her strength and resilience throughout her stage four melanoma battle.

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Researchers find molecule that drives skin cancer growth

A key protein helps fuel melanoma tumors — the deadliest form of skin cancer

The Independent UK

Top preventable cancer causes in UK revealed – and how to cut your risk

Researchers estimate that 7.1 million of the 18.7 million cancer cases diagnosed globally in 2022 were preventable

The Independent UK

Child aged 10 among 200 cases of illegal sunbed use as watchdog cracks down

Around 100 melanoma deaths in the UK each year are linked to sunbed use, according to charity Melanoma Focus

The Independent UK

Sunbed age crackdown to help protect teens from skin cancer danger

Mandatory ID checks could be introduced in sunbed shops across the UK

The Independent UK

‘A stranger told me to check a mole on my back for skin cancer - she saved my life’

A stranger’s warning on the street turned into a life-saving experience from skin cancer

Euronews

Promising vaccine for aggressive melanoma could unlock the body’s potential to fight cancer

A personalised mRNA vaccine developed by Moderna and Merck shows lasting benefits for patients with high-risk skin cancer.

The Independent UK

New personalized skin cancer treatment shows success in preventing return of high-risk melanoma

Patients with severe melanoma who received the treatment were 49% less likely to die or have their cancer return, pharmaceutical companies Moderna and Merck announced in five-year findings.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the World Health Organisation

221 stories

the Food and Drug Administration

the American Cancer Society

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.